Pharmacy
CVS Health and Catholic Health collaborate
CVS Accountable Care Organization, a division of the CVS Health family of businesses, announced it has entered into a collaboration with Catholic Health and Catholic Health Physician Partner’s ACO (Catholic Health) to expand value-based care and health care access for Medicare beneficiaries across t
CVS completes rollout of time delay safes in Florida, Hawaii, New Jersey and New York
CVS Health announced Tuesday that it has completed the installation of time delay safes in more than 9,000 CVS Pharmacy locations, including those in Target stores.
CVS Health names Brian Kane president of Aetna
CVS Health announced that Brian Kane will join the company as executive vice president and president of Aetna, effective September 1, 2023. He will become a member of the company’s executive leadership team and report to CVS Health president and CEO Karen Lynch.
Cardinal Health unveils two distribution centers in Central Ohio
Cardinal Health announced Monday that it is celebrating the opening of two new distribution centers in Central Ohio this month. Both facilities will support the company’s Medical Segment, focusing on its U.S. Medical Products and Distribution (USMPD) and at-Home Solutions businesses.
Community pharmacists cheer HHS extension of PREP Act authorities
ALEXANDRIA, Va. – The National Community Pharmacists Association is cheering today’s announcement by the U.S. Department of Health and Human Services that extend certain pharmacist authorities through December of 2024.
NACDS lauds major victory for patient access
ARLINGTON, Va. –The National Association of Chain Drug Stores (NACDS) is applauding the Biden Administration’s announcement today that it plans to preserve much of the pharmacy access that now is relied on and expected by Americans, through moves advocated by NACDS for more than a year.
NACDS Foundation awards $1 million to community-centered projects
NACDS Foundation announced its Request for Proposals (RFP) awardees.
American Council of the Blind applauds ScripTalk Talking Label pilot at Wegmans
The American Council of the Blind (ACB) announced that the ScripTalk Talking Prescription Label pilot program is now being impletemented at Wegmans Food Markets.
Walgreens, Prothena team to increase access Alzheimer’s disease clinical trial
Walgreens and Prothena announced Thursday a collaboration to accelerate patient identification and recruitment for Prothena’s ongoing ASCENT-2 multiple ascending dose clinical trial evaluating the safety and tolerability of PRX012, a potential best-in-class anti-amyloid beta antibody under developme
Federal court ensures access to abortion drug but with stricter rules
A federal appeals court has ruled that an abortion drug will remain available, under certain temporary restrictions. The new rules will mean mifepristone can only be prescribed by doctors – but can be approved for use up to ten weeks into pregnancy, rather than up to seven. The 5th U.S.
Aurobindo receives FDA nod for diclofenac sodium topical solution
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application diclofenac sodium topical solution USP, 2% w/w.
Aurobindo gets FDA approval for prazosin hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application prazosin hydrochloride capsules USP, 1mg, 2mg and 5mg.
Pharmacy benefit companies secure billions of dollars in savings for taxpayers
Pharmacy benefit companies are working every day to secure savings for patients, families, and taxpayers.
Aurobindo receives FDA approval for lansoprazole delayed-release orally disintegrating
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application lansoprazole delayed-release orally disintegrating tablets, 15 mg and 30 mg.
Texas federal judge suspends FDA approval of abortion pill
According to published reports, U.S. District Judge Matthew Kacsmaryk on Friday suspended the Food and Drug Administration’s longtime approval of key abortion pill mifepristone, though he gave the government a week to appeal his decision.